AGEs play a pivotal role in the development of chronic age-related diseases such as diabetes, renal failure and cardiovascular disease.
It is critical to assess the individual cardiovascular risk of your patients. Finding high risk patients early allows doctors to adjust treatement as soon as possible.
Find a distributor in your country. If your country is not listed, please contact DiagnOptics for your enquiries: email@example.com
Groningen, the Netherlands – February 6, 2014 Diagnoptics appointed Microcaya as the new distributor of its products in Spain. Microcaya will introduce ......» read more
The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or DiagnOptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.